Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiofrequency Haemorrhoidal Thermoablation Versus Doppler-guided Haemorrhoidal Artery Ligation With Mucopexy in the Treatment of Haemorrhoidal Disease: a Multicenter Randomized Non-inferiority Trial

NCT06170736 is registered in ClinicalTrials.gov with Centre Hospitalier Departemental Vendee as lead sponsor.

NCT NCT06170736
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06170736 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiofrequency Haemorrhoidal Thermoablation Versus Doppler-guided Haemorrhoidal Artery Ligation With Mucopexy in the Treatment of Haemorrhoidal Disease: a Multicenter Randomized Non-inferiority Trial
Lead sponsor
Centre Hospitalier Departemental Vendee
Phase
Not applicable
Overall status
Recruiting
Start date
February 21, 2024
Completion date
September 15, 2030
Enrollment
168 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

grade ii/iii haemorrhoids, haemorrhoids, internal haemorrhoids